These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 13763473)

  • 21. [STUDIES ON THE PROBLEM OF THE SO-CALLED LATE FAILURE OF SULFONYLUREA THERAPY].
    MEHNERT H; REISNER E
    Dtsch Med Wochenschr; 1964 Jul; 89():1378-84. PubMed ID: 14160351
    [No Abstract]   [Full Text] [Related]  

  • 22. [ORAL THERAPY OF DIABETES WITH SULFONYLUREA DERIVATIVES].
    OTTO H
    Medico (Eur); 1964; ():86-92. PubMed ID: 14171861
    [No Abstract]   [Full Text] [Related]  

  • 23. [A contribution to late results of sulfonylurea therapy].
    BIBERGEIL H
    Med Klin; 1961 Oct; 56():1786-91. PubMed ID: 13868940
    [No Abstract]   [Full Text] [Related]  

  • 24. [SULFONYLUREA SENSITIVITY: ITS SIGNIFICANCE IN THE THERAPY AND PROGNOSIS OF DIABETES MELLITUS].
    ANDREEV D
    Munch Med Wochenschr; 1964 Dec; 106():2259-62. PubMed ID: 14341467
    [No Abstract]   [Full Text] [Related]  

  • 25. [PROBLEMS OF LATE FAILURE OF ORAL SULFONYLUREA THERAPY OF DIABETES].
    STRAUZENBERG SE; HALLER H; MEYER H
    Schweiz Med Wochenschr; 1965 May; 95():628-36. PubMed ID: 14305109
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypoglycemic effects of 1-butyl-3-p-toluene sulfonylurea given orally in human diabetic subjects; a preliminary report.
    MILLER M; CRAIG JW
    Metabolism; 1956 Mar; 5(2):162-4. PubMed ID: 13296878
    [No Abstract]   [Full Text] [Related]  

  • 27. [ON THE CLINICAL ADJUSTABILITY OF VARIOUS FORMS OF DIABETES IN DELAYED-ACTION INSULIN THERAPY, COMBINED AND EXCLUSIVELY ORAL THERAPY WITH SULFONYLUREA DERIVATIVES AND BIGUANIDES].
    KNICK B; FOLKERT F
    Munch Med Wochenschr; 1965 Jan; 107():83-8. PubMed ID: 14301179
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diabetes therapy using oral antidiabetics].
    Hasslacher C; Wahl P
    Z Allgemeinmed; 1972 Apr; 48(12):583-7. PubMed ID: 5034166
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination of DBI with a sulfonylurea in diabetic therepy.
    JONCAS F
    Appl Ther; 1962 May; 4():476-9. PubMed ID: 14452210
    [No Abstract]   [Full Text] [Related]  

  • 30. PREDIABETES AND THE EFFECT OF SULPHONYLUREA IN ITS TREATMENT.
    MODI NJ
    J Assoc Physicians India; 1964 Jul; 12():495-500. PubMed ID: 14184092
    [No Abstract]   [Full Text] [Related]  

  • 31. [POSSIBLE NON-DIABETIC EFFECTS OF SULFONYLUREA].
    BAUER G
    Medico (Eur); 1963; ():117-21. PubMed ID: 14065436
    [No Abstract]   [Full Text] [Related]  

  • 32. Thyroid function in diabetic patients under long-term sulfonylurea treatment.
    NIKKILA EA; JAKOBSON T; JOKIPII SG; KARLSSON K
    Acta Endocrinol (Copenh); 1960 Apr; 33():623-9. PubMed ID: 14427195
    [No Abstract]   [Full Text] [Related]  

  • 33. [New indications for sulfonylureas?].
    LEUTIGER H
    Med Welt; 1962 Aug; 33():1698-1700. PubMed ID: 14464451
    [No Abstract]   [Full Text] [Related]  

  • 34. [The "diabetoid states" of pregnancy and their treatment with oral antidiabetics].
    LOPEZ FERNANDEZ RJ
    Rev Esp Obstet Ginecol; 1961; 20():175-85. PubMed ID: 14466588
    [No Abstract]   [Full Text] [Related]  

  • 35. CYCLAMIDE (K-386) TREATMENT OF DIABETES MELLITUS.
    GRINCHENKO TS
    Fed Proc Transl Suppl; 1964; 23():767-8. PubMed ID: 14196927
    [No Abstract]   [Full Text] [Related]  

  • 36. Diabetic control with chlorpropamide in a psychiatric hospital: a preliminary report.
    LUPO TG; TARNOWSKI SM
    Am J Psychiatry; 1961 Jul; 118():77-8. PubMed ID: 13764373
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of diabetes in pregnancy with hypoglycemic sulfonamides and possible repercussions on the fetus. (Clinico-experimental considerations)].
    CANTALUPPI GF
    Minerva Ginecol; 1961 Nov; 13():1188-91. PubMed ID: 13876254
    [No Abstract]   [Full Text] [Related]  

  • 38. [CLINICAL EVALUATION OF TOLCYCLAMIDE, A HYPOGLYCEMIC AGENT WITHOUT DEMONSTRABLE TOXICITY].
    VARGAS L; LIEBERMAN E; DOMENGE L; LOZANO O
    Rev Invest Clin; 1964; 16():449-62. PubMed ID: 14308569
    [No Abstract]   [Full Text] [Related]  

  • 39. [The combination DBI-sulfonylurea derivative for diabetes mellitus].
    JAKOBSON T
    Nord Med; 1962 May; 67():585-9. PubMed ID: 14450955
    [No Abstract]   [Full Text] [Related]  

  • 40. [Oral antidiabetics today].
    Aro A
    Duodecim; 1981; 97(12):837-47. PubMed ID: 7297451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.